The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index; 166 of the 371 sources its claims cite were checked for support.
Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes
Open accessAbstract
Biomaterials are defined as "engineered materials" and include a range of natural and synthetic products, designed for their introduction into and interaction with living tissues. Biomaterials are considered prominent tools in regenerative medicine that support the restoration of tissue defects and retain physiologic functionality. Although commonly used in the medical field, these constructs are inherently foreign toward the host and induce an immune response at the material-tissue interface, defined as the foreign body response (FBR). A strong connection between the foreign body response and tissue regeneration is suggested, in which an appropriate amount of immune response and macrophage polarization is necessary to trigger autologous tissue formation. Recent developments in this field have led to the characterization of immunomodulatory traits that optimizes bioactivity, the integration of biomaterials and determines the fate of tissue regeneration. This review addresses a variety of aspects that are involved in steering the inflammatory response, including immune cell interactions, physical characteristics, biochemical cues, and metabolomics. Harnessing the advancing knowledge of the FBR allows for the optimization of biomaterial-based implants, aiming to prevent damage of the implant, improve natural regeneration, and provide the tools for an efficient and successful in vivo implantation.
Overview
CoChat Summary
## TL;DR
This is a review of how biomaterial properties and the immune microenvironment shape the foreign body response (FBR) and tissue regeneration. It argues that tuning physical, biochemical, and metabolic cues can shift inflammation toward a regenerative phenotype and improve implant integration.
## Key findings
- The review states that biomaterial implantation always triggers an immune response and that improper integration can lead to chronic inflammation, fibrous capsule formation, isolation, or rejection of the implant; it also says no material currently exists that is biologically accepted and free of adverse effects.
- Size, geometry, topography, stiffness, porosity, and wettability all influence immune behavior: for example, smaller PLGA 5 µm microspheres showed cellular and macrophage influx, phagocytosis, and collagen deposition, while 29.8 µm spheres induced only occasional FBGCs; spheres ≤0.5 mm induced severe FBR whereas 1.5 mm spheres scarcely did.
- Several cited studies suggest surface and scaffold design can favor anti-inflammatory polarization: rough-hydrophilic titanium surfaces increased Th2/Treg-related genes after 3 days, 400–500 nm grooves on titanium gave the highest IL-10 and Arg1-positive cells, and 40–60 µm pore PCL scaffolds promoted M2 markers such as CD163/CD206 and IL-10.
- Biochemical cues can be leveraged to steer repair: in one example, IL-4-releasing biomaterial conduits led to a significant increase in M2 macrophages and axon regeneration 20 times greater than IFN-γ-releasing tubes; in another, PDGF-ββ/FGF-2 supported macrophage infiltration before robust vessel formation and pericyte recruitment.
## Methods
- Narrative review of recent literature on biomaterials and immune responses at the cell–biomaterial interface, organized around implantation/FBR, inflammatory cell types, physical properties, biochemical cues, and metabolomics.
- Synthesizes evidence from in vitro studies, in vivo animal models (including mice, rats, rabbits, sheep, pigs, and primates), and coculture systems across many biomaterial classes.
- No single new experimental dataset or primary statistical analysis is reported in the paper itself; the paper compiles and interprets findings from prior studies.
## Limitations
- The paper explicitly notes several places where the evidence remains incomplete or mixed: for example, “further investigation” is needed for different implant architectures, the exact optimal roughness was not determined in some studies, and long-term stability should be confirmed for some sequential growth-factor releases.
- The text makes evident that much of the evidence is study-specific and not directly comparable across materials, shapes, cell types, and implantation sites; this limits generalization of any single “best” design choice (evident from the heterogeneous examples summarized).
- The paper explicitly states that some approaches were only tested in vitro and need in vivo validation, such as GAG-coated biomaterials; it also notes several cases where in vitro and in vivo results did not match.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
151 Valid · 11 Not valid · 180 Not checked · 47 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Seeding the scaffolds with either regular effective Th cells (CD4+) or cells subduing Th2 polarization (Rictor −/− or Il4ra −/−) also showed a lack of CD206 in the microenvironment, a marker for M2 macrophage polarization.”
§ Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes > Response of Inflammatory Cell Types to Biomaterials > T‐Helper Lymphocytes
What the sources say
- Disputedcites [78] K. Sadtler, K. Estrellas, B. W. Allen, M. T. Wolf, H. Fan, A. J. Tam, C. H. Patel, B. S. Luber, H. Wang, K. R. Wagner, J. D. Powell, F. Housseau, D. M. Pardoll, J. H. Elisseeff, Science 2016, 352, 366. 27081073 PMC4866509 sourceExperimental — accuracy not yet measured
The passage labeled Abstract reports that wild-type CD4+ T cells rescued CD206 expression in repopulated Rag1−/− mice, contrary to the claim that regular CD4+ cells showed a lack of CD206. It reports lower CD206 with Rictor−/− T cells and in Il4ra−/− wounds, but the Il4ra−/− experiment used mice unable to receive IL-4 signals, not transferred T cells. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Studies on synthetic polymers, PCL and poly(l‐lactic) (PLLA) showed reduced FBR in 3D electrospun scaffolds compared to 2D films.[ 41 , 128 ]”
§ Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes > Response of Inflammatory Cell Types to Biomaterials > Complex Structures: Fiber and Pore Size
What the sources say
- Not checked — no full text of the sourcecites [41] E. Saino, M. L. Focarete, C. Gualandi, E. Emanuele, A. I. Cornaglia, M. Imbriani, L. Visai, Biomacromolecules 2011, 12, 1900. 21417396 source
- Disputedcites [128] H. Cao, K. McHugh, S. Y. Chew, J. M. Anderson, J. Biomed. Mater. Res., A 2010, 93, 1151. 19768795 PMC9069486 sourceExperimental — accuracy not yet measured
The Results (‘Foreign body reaction and fibrous capsule formation’; page unavailable) report intense foreign body reaction on random PCL fibers, while aligned fibers and PCL film had more quiescent reactions. The Discussion says the reaction was most severe on random fibers and least on film. Although both fiber scaffolds produced thinner fibrous capsules than film, that does not establish the claimed reduction in foreign body reaction. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Chronic inflammation can be found around most synthetic materials postimplantation.[ 29 , 45 , 46 ]”
§ Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes > Biomaterial Integration, the Foreign Body Response, and Wound Healing
What the sources say
- Not checked — no full text of the sourcecites [29] J. Anderson, S. Cramer, in Host Response to Biomaterials (Ed.: S. F. Badylak), Academic Press, Oxford, 2015, pp. 13– 36. source
- Not checked — no full text of the sourcecites [45] K. Sadtler, M. T. Wolf, S. Ganguly, C. A. Moad, L. Chung, S. Majumdar, F. Housseau, D. M. Pardoll, J. H. Elisseeff, Biomaterials 2019, 192, 405. 30500722 source
- Could not verifycites [46] T. Browder, J. Folkman, S. Pirie‐Shepherd, J. Biol. Chem. 2000, 275, 1521. 10636838 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) addresses clotting, angiogenesis, and vessel repair, not the response to implanted synthetic materials. Searches for chronic inflammation, implants, biomaterials, and foreign-body responses found no passage addressing whether inflammation occurs around most synthetic materials after implantation. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Persistent foreign material degradation can continuously activate M1 macrophages.[ 39 ]”
§ Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes > Biomaterial Integration, the Foreign Body Response, and Wound Healing
What the sources say
- Partly supportedcites [39] B. N. Brown, R. Londono, S. Tottey, L. Zhang, K. A. Kukla, M. T. Wolf, K. A. Daly, J. E. Reing, S. F. Badylak, Acta Biomater. 2012, 8, 978. 22166681 PMC4325370 sourceExperimental — accuracy not yet measured
The Results (§4.2; page unavailable) report predominantly M1 macrophages around implanted mesh at both 14 and 35 days, supporting a sustained M1 response to foreign material. But §4.1 reports little to no degradation in that group, while rapidly degrading materials showed a different response. The paper does not establish that persistent degradation continuously activates M1 macrophages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Acute inflammation can therefore result in a toxic environment that may damage or destroy the functionality of an implant.[ 22 , 43 , 44 ]”
§ Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes > Biomaterial Integration, the Foreign Body Response, and Wound Healing
What the sources say
- Supportedcites [22] J. D. Bryers, C. M. Giachelli, B. D. Ratner, Biotechnol. Bioeng. 2012, 109, 1898. 22592568 PMC3490630 source
The FBR Overview (page unavailable) says acute inflammation releases lysosomal proteases and oxygen free radicals in an attempt to degrade the implanted material. The Introduction (page unavailable) identifies the resulting foreign body reaction as a major route of implant-device failure. Together, these support the hedged claim that this inflammatory environment may damage an implant’s functionality. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [43] P. M. Henson, Am. J. Pathol. 1980, 101, 494. 7004205 PMC1903647
- Not checked — no full text of the sourcecites [44] A. G. Mikos, L. V. McIntire, J. M. Anderson, J. E. Babensee, Adv. Drug Deliv. Rev. 1998, 33, 111. 10837656 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
158 more claims · 61 with their cited sources checked
Create a free account to see all 389 claims and to verify the 28 references still open.
- It may state two separate claims as one. 211
- Probably not a substantial claim. 29
- The quote only partly states this claim. 2
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Research works printed but not linked: 13
- Katari R., 2014, Front Bioeng Biotechnol., 2, 57
- Zakrzewski J., 2014, Nat. Biotechnol., 32
- Henson P. M., 1980, Am. J. Pathol., 101, 494
- Yu T., 2015, The Role of Macrophages in the Foreign Body Response to Implanted Biomaterials. Biomaterials in Regenerative Medicine and the Immune System, 17
- Alberts B., 2008, Molecular Biology of the Cell. [Hauptbd.]. [Hauptbd.]
- Ratner B., 2012, Biomater. Sci.
- Vojdani A., 2006, Complement Altern. Med., 3, 309
- Desmoulière A., 1995, Am. J. Pathol., 146, 56
- Kapalczynska M., 2018, Arch. Med. Sci., 14, 910
- 10.1016/j.actbio.2013.10.035 · DOI · Paper page
- Shakibania S., 2020, Drug Dev. Ind. Pharm., 1
- Göktürk E., 2017, Sakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 21
- Kim Y. H., 2015, J. Biomed. Mater. Res., A
Cited by
Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine
Wei, L., Yan, W., Shah, W., Zhang, Z., Wang, M., Liu, B., Xue, Z., Cao, Y., Hou, X., Zhang, K., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35836 · Cited by 79
“Implanting these structures in dogs has improved intestinal mucosa regeneration, suggesting therapeutic benefits for tissue loss in diverse conditions [57].”
BackgroundApplication of 3D Printing Technology in Dentistry: A Review
Chen, Y., & Wei, J. (2025) · Polymers · doi:10.3390/polym17070886 · Cited by 79
“…environment of the body, which cannot maintain long-term efficacy, how to enhance the adhesion between the biological materials and the substrate, and obtain the integrated multifunctional active, good biocompatibility and durability of printed implants is the key issue in the current study [31].”
Smart nanomaterials for multimodal theranostics and tissue regeneration
Lee, H., Kim, K. S., Zare, I., Bang, S., Kang, H., Moon, C.-H., Gwon, J. Y., Seo, J., Joo, H., Cho, Y.-S., et al. (2025) · Coordination chemistry reviews · doi:10.1016/j.ccr.2025.216801 · Cited by 51
Formation and biological activities of foreign body giant cells in response to biomaterials
Cai, F., Jiang, B., & He, F. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.08.034 · Cited by 47
Hierarchy Reproduction: Multiphasic Strategies for Tendon/Ligament–Bone Junction Repair
Chen, K., Liu, Z., Zhou, X., Zheng, W., Cao, H., Yang, Z., Wang, Z., Ning, C., Li, Q., & Zhao, H. (2025) · Biomaterials Research · doi:10.34133/bmr.0132 · Cited by 25
“Biomaterial topology emphasizes the combination of geometric advantages and intrinsic material properties to enhance bioaf-finity and tissue regeneration promotion [ 61 ].”
Metadata
- Authors
- ten Brink, T., Damanik, F., Rotmans, J. I., & Moroni, L.
- Affiliations
- Complex Tissue Regeneration Department MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University Universiteitssingel 40 Maastricht 6229ER The Netherlands
- Maastricht University (NL)
- Leiden University Medical Center (NL)
- Corresponding author
- Moroni, Lorenzo
- Venue
- Advanced Healthcare Materials
- Publisher
- Wiley
- Published
- 2024-04-05
- Volume
- 13
- Issue
- 17
- Pages
- e2301939-e2301939
- ISSN
- 2192-2640 (ISSN-L)
- 2192-2659
- PMC
- PMC11468937
- OpenAlex
- W4390841222
- Cited by
- 71
- References
- 279
- Citations by year
- 2026: 41 · 2025: 22 · 2024: 8
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Advanced Healthcare Materials (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
- Funders
- European Research Council (637308)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- foreign body reaction, biomaterials, tissue engineering, macrophage polarization, immunomodulation, inflammation, tissue regeneration, implant integration, metabolomics, bioactivity (biomaterials), regenerative medicine
- MeSH terms
- Animals, Biocompatible Materials, Foreign-Body Reaction, Humans, Tissue Engineering, Regenerative Medicine, Tissue Scaffolds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes. https://app.cochat.ai/papers/10.1002/adhm.202301939
- The paper
- ten Brink, T., Damanik, F., Rotmans, J. I., & Moroni, L. (2024). Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301939
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.